UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$438M |
| 2 |
Lockheed Martin
LMT
|
+$402M |
| 3 |
TAL Education Group
TAL
|
+$294M |
| 4 |
Microsoft
MSFT
|
+$269M |
| 5 |
Wells Fargo
WFC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$384M |
| 2 |
Adobe
ADBE
|
+$372M |
| 3 |
Veeva Systems
VEEV
|
+$342M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$289M |
| 5 |
Global Payments
GPN
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.1% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
BioNTech
BNTX
$23.5B
| $22.9M | 0.01% |
281,282
+141,090
| +101% | +$13.9M |
|
|
SEE
777
DELISTED
Sealed Air
SEE
| $22.9M | 0.01% |
500,648
+29,065
| +6% | +$1.26M |
|
778
Charles River Laboratories
CRL
$12.8B
| $22.9M | 0.01% |
91,696
+11,266
| +14% | +$2.68M |
|
779
CareDx
CDNA
$2.42B
| $22.5M | 0.01% |
310,933
-84,931
| -21% | -$4.92M |
|
780
Graco
GGG
$13.5B
| $22.4M | 0.01% |
309,675
+66,996
| +28% | +$4.48M |
|
781
Entegris
ENTG
$23.2B
| $22.4M | 0.01% |
232,668
+33,338
| +17% | +$2.91M |
|
782
MaxLinear
MXL
$6.8B
| $22.3M | 0.01% |
583,367
+526,848
| +932% | +$15.3M |
|
|
DCPH
783
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $22.2M | 0.01% |
388,211
+104,822
| +37% | +$6.21M |
|
784
Brookfield Renewable
BEPC
$6.26B
| $22M | 0.01% |
+377,602
| New | +$18.2M |
|
785
Medpace
MEDP
$16.5B
| $22M | 0.01% |
157,827
-6,091
| -4% | -$768K |
|
786
Dropbox
DBX
$8.12B
| $21.9M | 0.01% |
987,004
-716,417
| -42% | -$14.6M |
|
|
AIMC
787
DELISTED
Altra Industrial Motion Corp
AIMC
| $21.7M | 0.01% |
391,974
-23,191
| -6% | -$1.14M |
|
788
American Financial Group
AFG
$12.1B
| $21.5M | 0.01% |
245,262
+7,264
| +3% | +$596K |
|
789
Agree Realty
ADC
$9.41B
| $21.5M | 0.01% |
322,525
+39,180
| +14% | +$2.56M |
|
|
NUAN
790
DELISTED
Nuance Communications, Inc.
NUAN
| $21.1M | 0.01% |
479,479
+30,318
| +7% | +$1.15M |
|
|
BLUE
791
DELISTED
bluebird bio
BLUE
| $21M | 0.01% |
37,546
+11,667
| +45% | +$7.39M |
|
792
Autoliv
ALV
$9B
| $21M | 0.01% |
228,143
+1,635
| +0.7% | +$141K |
|
793
Carlisle Companies
CSL
$15.4B
| $20.9M | 0.01% |
134,079
+50,176
| +60% | +$7.05M |
|
794
Snowflake
SNOW
$115B
| $20.9M | 0.01% |
74,292
+18,112
| +32% | +$5.15M |
|
795
Lattice Semiconductor
LSCC
$18.5B
| $20.8M | 0.01% |
454,781
-27,696
| -6% | -$1.07M |
|
|
SIX
796
DELISTED
Six Flags Entertainment Corp.
SIX
| $20.8M | 0.01% |
608,816
+489,709
| +411% | +$13.4M |
|
797
Sabra Healthcare REIT
SBRA
$5.37B
| $20.7M | 0.01% |
1,191,742
+167,291
| +16% | +$2.67M |
|
|
DOC
798
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $20.6M | 0.01% |
1,158,476
+274,709
| +31% | +$4.92M |
|
799
argenx
ARGX
$54.1B
| $20.6M | 0.01% |
70,096
+21,761
| +45% | +$5.98M |
|
|
AZEK
800
DELISTED
The AZEK Co
AZEK
| $20.6M | 0.01% |
535,267
+433,683
| +427% | +$15.7M |
|
Similar funds
UBS AM's Q4 2020 Portfolio in Review
As of Q4 2020, UBS AM held 2,632 positions worth $213B, up 15% from $186B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM's Q4 2020 filing shows 139 new, 1,393 increased, 625 reduced and 83 closed positions. Its largest new stake was Maravai LifeSciences: 3,763,012 shares worth $106M. The largest sale was Mastercard, an estimated $384M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q4 2020 buy was Maravai LifeSciences: 3,763,012 shares worth $106M.
- UBS AM added most to Apple in Q4 2020, an estimated $438M increase.
- UBS AM's biggest Q4 2020 reduction was Mastercard, cutting an estimated $384M.
- UBS AM fully exited State Street Technology Select Sector SPDR ETF in Q4 2020, selling an estimated $115M.
- UBS AM's ten largest holdings make up 23% of its $213B portfolio in Q4 2020.
- UBS AM opened 139 new positions and closed 83 in Q4 2020.
- UBS AM's portfolio value rose 15% quarter-over-quarter to $213B.
Based on UBS AM's 13F filing for Q4 2020, filed 17 Feb 2021.